HealthEquity (HQY) to Release Quarterly Earnings on Monday

HealthEquity (NASDAQ:HQY - Get Free Report) is set to issue its quarterly earnings data after the market closes on Monday, December 9th. Analysts expect the company to announce earnings of $0.71 per share for the quarter. HealthEquity has set its FY25 guidance at 2.98-3.14 EPS and its FY 2025 guidance at 2.980-3.140 EPS.Persons that are interested in registering for the company's earnings conference call can do so using this link.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. The firm had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. On average, analysts expect HealthEquity to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

HealthEquity Trading Up 0.1 %

HQY traded up $0.12 during mid-day trading on Monday, reaching $101.66. The stock had a trading volume of 581,699 shares, compared to its average volume of 625,457. The firm's fifty day simple moving average is $90.16 and its two-hundred day simple moving average is $82.85. The stock has a market capitalization of $8.88 billion, a P/E ratio of 84.62, a P/E/G ratio of 1.59 and a beta of 0.52. HealthEquity has a 52 week low of $62.10 and a 52 week high of $105.82. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

Insider Buying and Selling at HealthEquity

In other news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Frank Corvino sold 1,247 shares of the firm's stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now owns 4,823 shares of the company's stock, valued at approximately $387,093.98. This represents a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 10,536 shares of company stock valued at $884,517. 2.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

HQY has been the subject of a number of recent research reports. BTIG Research boosted their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research note on Thursday, November 14th. Barrington Research raised their price target on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Monday. Bank of America lifted their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research note on Wednesday, November 13th. Royal Bank of Canada reissued an "outperform" rating and issued a $92.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $102.00 to $103.00 and gave the stock a "buy" rating in a report on Wednesday, September 4th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, HealthEquity presently has a consensus rating of "Moderate Buy" and an average target price of $108.38.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.